img

Global Dermatology OTC Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Dermatology OTC Drug Market Insights, Forecast to 2034

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Market Analysis and InsightsGlobal Dermatology OTC Drug Market
Global Dermatology OTC Drug market is expected to reach to US$ 13290 million in 2023, with a positive growth of %, compared with US$ 12780 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Dermatology OTC Drug industry is evaluated to reach US$ 16340 million in 2033. The CAGR will be 3.5% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Dermatology OTC Drug market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Dermatology OTC Drug market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
GSK
Teva
Johnson & Johnson
Novartis
Viatris
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Livzon
Almirall
Lingrui
Segment by Type
Antifungals Medication
Skin Disinfection Medication
Skin Irritation Medication
Wounds and Herpes Simplex Medication
Anti-Psoriasis Medication
Other

Segment by Application


Hospital
Drug Store
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Dermatology OTC Drug introduction, etc. Dermatology OTC Drug Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Dermatology OTC Drug
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Antifungals Medication
1.2.3 Skin Disinfection Medication
1.2.4 Skin Irritation Medication
1.2.5 Wounds and Herpes Simplex Medication
1.2.6 Anti-Psoriasis Medication
1.2.7 Other
1.3 Market by Application
1.3.1 Global Dermatology OTC Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatology OTC Drug Market Perspective (2018-2033)
2.2 Global Dermatology OTC Drug Growth Trends by Region
2.2.1 Dermatology OTC Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Dermatology OTC Drug Historic Market Size by Region (2018-2023)
2.2.3 Dermatology OTC Drug Forecasted Market Size by Region (2024-2033)
2.3 Dermatology OTC Drug Market Dynamics
2.3.1 Dermatology OTC Drug Industry Trends
2.3.2 Dermatology OTC Drug Market Drivers
2.3.3 Dermatology OTC Drug Market Challenges
2.3.4 Dermatology OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Dermatology OTC Drug by Players
3.1.1 Global Dermatology OTC Drug Revenue by Players (2018-2023)
3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2018-2023)
3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dermatology OTC Drug, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Dermatology OTC Drug Market Concentration Ratio
3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2022
3.5 Global Key Players of Dermatology OTC Drug Head office and Area Served
3.6 Global Key Players of Dermatology OTC Drug, Product and Application
3.7 Global Key Players of Dermatology OTC Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology OTC Drug Breakdown Data by Type
4.1 Global Dermatology OTC Drug Historic Market Size by Type (2018-2023)
4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2033)
5 Dermatology OTC Drug Breakdown Data by Application
5.1 Global Dermatology OTC Drug Historic Market Size by Application (2018-2023)
5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Dermatology OTC Drug Market Size (2018-2033)
6.2 North America Dermatology OTC Drug Market Size by Type
6.2.1 North America Dermatology OTC Drug Market Size by Type (2018-2023)
6.2.2 North America Dermatology OTC Drug Market Size by Type (2024-2033)
6.2.3 North America Dermatology OTC Drug Market Share by Type (2018-2033)
6.3 North America Dermatology OTC Drug Market Size by Application
6.3.1 North America Dermatology OTC Drug Market Size by Application (2018-2023)
6.3.2 North America Dermatology OTC Drug Market Size by Application (2024-2033)
6.3.3 North America Dermatology OTC Drug Market Share by Application (2018-2033)
6.4 North America Dermatology OTC Drug Market Size by Country
6.4.1 North America Dermatology OTC Drug Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Dermatology OTC Drug Market Size by Country (2018-2023)
6.4.3 North America Dermatology OTC Drug Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Dermatology OTC Drug Market Size (2018-2033)
7.2 Europe Dermatology OTC Drug Market Size by Type
7.2.1 Europe Dermatology OTC Drug Market Size by Type (2018-2023)
7.2.2 Europe Dermatology OTC Drug Market Size by Type (2024-2033)
7.2.3 Europe Dermatology OTC Drug Market Share by Type (2018-2033)
7.3 Europe Dermatology OTC Drug Market Size by Application
7.3.1 Europe Dermatology OTC Drug Market Size by Application (2018-2023)
7.3.2 Europe Dermatology OTC Drug Market Size by Application (2024-2033)
7.3.3 Europe Dermatology OTC Drug Market Share by Application (2018-2033)
7.4 Europe Dermatology OTC Drug Market Size by Country
7.4.1 Europe Dermatology OTC Drug Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Dermatology OTC Drug Market Size by Country (2018-2023)
7.4.3 Europe Dermatology OTC Drug Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Dermatology OTC Drug Market Size (2018-2033)
8.2 China Dermatology OTC Drug Market Size by Type
8.2.1 China Dermatology OTC Drug Market Size by Type (2018-2023)
8.2.2 China Dermatology OTC Drug Market Size by Type (2024-2033)
8.2.3 China Dermatology OTC Drug Market Share by Type (2018-2033)
8.3 China Dermatology OTC Drug Market Size by Application
8.3.1 China Dermatology OTC Drug Market Size by Application (2018-2023)
8.3.2 China Dermatology OTC Drug Market Size by Application (2024-2033)
8.3.3 China Dermatology OTC Drug Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Dermatology OTC Drug Market Size (2018-2033)
9.2 Asia Dermatology OTC Drug Market Size by Type
9.2.1 Asia Dermatology OTC Drug Market Size by Type (2018-2023)
9.2.2 Asia Dermatology OTC Drug Market Size by Type (2024-2033)
9.2.3 Asia Dermatology OTC Drug Market Share by Type (2018-2033)
9.3 Asia Dermatology OTC Drug Market Size by Application
9.3.1 Asia Dermatology OTC Drug Market Size by Application (2018-2023)
9.3.2 Asia Dermatology OTC Drug Market Size by Application (2024-2033)
9.3.3 Asia Dermatology OTC Drug Market Share by Application (2018-2033)
9.4 Asia Dermatology OTC Drug Market Size by Region
9.4.1 Asia Dermatology OTC Drug Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Dermatology OTC Drug Market Size by Region (2018-2023)
9.4.3 Asia Dermatology OTC Drug Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Dermatology OTC Drug Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Dermatology OTC Drug Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatology OTC Drug Introduction
11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2018-2023)
11.1.5 Bayer Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dermatology OTC Drug Introduction
11.2.4 GSK Revenue in Dermatology OTC Drug Business (2018-2023)
11.2.5 GSK Recent Developments
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Dermatology OTC Drug Introduction
11.3.4 Teva Revenue in Dermatology OTC Drug Business (2018-2023)
11.3.5 Teva Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatology OTC Drug Introduction
11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Dermatology OTC Drug Introduction
11.6.4 Viatris Revenue in Dermatology OTC Drug Business (2018-2023)
11.6.5 Viatris Recent Developments
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Details
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023)
11.7.5 Sun Pharmaceutical Recent Developments
11.8 Aurobindo
11.8.1 Aurobindo Company Details
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatology OTC Drug Introduction
11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023)
11.8.5 Aurobindo Recent Developments
11.9 Galderma
11.9.1 Galderma Company Details
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatology OTC Drug Introduction
11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2018-2023)
11.9.5 Galderma Recent Developments
11.10 CR SANJIU
11.10.1 CR SANJIU Company Details
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatology OTC Drug Introduction
11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023)
11.10.5 CR SANJIU Recent Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Details
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Dermatology OTC Drug Introduction
11.11.4 Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023)
11.11.5 Dr. Reddy's Recent Developments
11.12 Lupin
11.12.1 Lupin Company Details
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatology OTC Drug Introduction
11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2018-2023)
11.12.5 Lupin Recent Developments
11.13 Bausch Health
11.13.1 Bausch Health Company Details
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatology OTC Drug Introduction
11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023)
11.13.5 Bausch Health Recent Developments
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatology OTC Drug Introduction
11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2018-2023)
11.14.5 Cipla Recent Developments
11.15 Livzon
11.15.1 Livzon Company Details
11.15.2 Livzon Business Overview
11.15.3 Livzon Dermatology OTC Drug Introduction
11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2018-2023)
11.15.5 Livzon Recent Developments
11.16 Almirall
11.16.1 Almirall Company Details
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatology OTC Drug Introduction
11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2018-2023)
11.16.5 Almirall Recent Developments
11.17 Lingrui
11.17.1 Lingrui Company Details
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatology OTC Drug Introduction
11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2018-2023)
11.17.5 Lingrui Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Antifungals Medication
Table 3. Key Players of Skin Disinfection Medication
Table 4. Key Players of Skin Irritation Medication
Table 5. Key Players of Wounds and Herpes Simplex Medication
Table 6. Key Players of Anti-Psoriasis Medication
Table 7. Key Players of Other
Table 8. Global Dermatology OTC Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 9. Global Dermatology OTC Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Dermatology OTC Drug Market Share by Region (2018-2023)
Table 12. Global Dermatology OTC Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Dermatology OTC Drug Market Share by Region (2024-2033)
Table 14. Dermatology OTC Drug Market Trends
Table 15. Dermatology OTC Drug Market Drivers
Table 16. Dermatology OTC Drug Market Challenges
Table 17. Dermatology OTC Drug Market Restraints
Table 18. Global Dermatology OTC Drug Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Dermatology OTC Drug Revenue Share by Players (2018-2023)
Table 20. Global Top Dermatology OTC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Table 21. Global Dermatology OTC Drug Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Dermatology OTC Drug, Headquarters and Area Served
Table 24. Global Key Players of Dermatology OTC Drug, Product and Application
Table 25. Global Key Players of Dermatology OTC Drug, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2018-2023)
Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2024-2033)
Table 31. Global Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Dermatology OTC Drug Revenue Share by Application (2018-2023)
Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Dermatology OTC Drug Revenue Share by Application (2024-2033)
Table 35. North America Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Dermatology OTC Drug Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Dermatology OTC Drug Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Dermatology OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Dermatology OTC Drug Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Dermatology OTC Drug Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Dermatology OTC Drug Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Dermatology OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Europe Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Dermatology OTC Drug Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Dermatology OTC Drug Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Dermatology OTC Drug Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Dermatology OTC Drug Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Dermatology OTC Drug Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Dermatology OTC Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 58. Asia Dermatology OTC Drug Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Dermatology OTC Drug Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Dermatology OTC Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 65. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size by Country (2024-2033) & (US$ Million)
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Dermatology OTC Drug Product
Table 70. Bayer Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 71. Bayer Recent Developments
Table 72. GSK Company Details
Table 73. GSK Business Overview
Table 74. GSK Dermatology OTC Drug Product
Table 75. GSK Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 76. GSK Recent Developments
Table 77. Teva Company Details
Table 78. Teva Business Overview
Table 79. Teva Dermatology OTC Drug Product
Table 80. Teva Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 81. Teva Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Dermatology OTC Drug Product
Table 85. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Dermatology OTC Drug Product
Table 90. Novartis Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Viatris Company Details
Table 93. Viatris Business Overview
Table 94. Viatris Dermatology OTC Drug Product
Table 95. Viatris Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 96. Viatris Recent Developments
Table 97. Sun Pharmaceutical Company Details
Table 98. Sun Pharmaceutical Business Overview
Table 99. Sun Pharmaceutical Dermatology OTC Drug Product
Table 100. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 101. Sun Pharmaceutical Recent Developments
Table 102. Aurobindo Company Details
Table 103. Aurobindo Business Overview
Table 104. Aurobindo Dermatology OTC Drug Product
Table 105. Aurobindo Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 106. Aurobindo Recent Developments
Table 107. Galderma Company Details
Table 108. Galderma Business Overview
Table 109. Galderma Dermatology OTC Drug Product
Table 110. Galderma Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 111. Galderma Recent Developments
Table 112. CR SANJIU Company Details
Table 113. CR SANJIU Business Overview
Table 114. CR SANJIU Dermatology OTC Drug Product
Table 115. CR SANJIU Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 116. CR SANJIU Recent Developments
Table 117. Dr. Reddy's Company Details
Table 118. Dr. Reddy's Business Overview
Table 119. Dr. Reddy's Dermatology OTC Drug Product
Table 120. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 121. Dr. Reddy's Recent Developments
Table 122. Lupin Company Details
Table 123. Lupin Business Overview
Table 124. Lupin Dermatology OTC Drug Product
Table 125. Lupin Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 126. Lupin Recent Developments
Table 127. Bausch Health Company Details
Table 128. Bausch Health Business Overview
Table 129. Bausch Health Dermatology OTC Drug Product
Table 130. Bausch Health Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 131. Bausch Health Recent Developments
Table 132. Cipla Company Details
Table 133. Cipla Business Overview
Table 134. Cipla Dermatology OTC Drug Product
Table 135. Cipla Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 136. Cipla Recent Developments
Table 137. Livzon Company Details
Table 138. Livzon Business Overview
Table 139. Livzon Dermatology OTC Drug Product
Table 140. Livzon Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 141. Livzon Recent Developments
Table 142. Almirall Company Details
Table 143. Almirall Business Overview
Table 144. Almirall Dermatology OTC Drug Product
Table 145. Almirall Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 146. Almirall Recent Developments
Table 147. Lingrui Company Details
Table 148. Lingrui Business Overview
Table 149. Lingrui Dermatology OTC Drug Product
Table 150. Lingrui Revenue in Dermatology OTC Drug Business (2018-2023) & (US$ Million)
Table 151. Lingrui Recent Developments
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology OTC Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Dermatology OTC Drug Market Share by Type: 2022 VS 2033
Figure 3. Antifungals Medication Features
Figure 4. Skin Disinfection Medication Features
Figure 5. Skin Irritation Medication Features
Figure 6. Wounds and Herpes Simplex Medication Features
Figure 7. Anti-Psoriasis Medication Features
Figure 8. Other Features
Figure 9. Global Dermatology OTC Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global Dermatology OTC Drug Market Share by Application: 2022 VS 2033
Figure 11. Hospital Case Studies
Figure 12. Drug Store Case Studies
Figure 13. Other Case Studies
Figure 14. Dermatology OTC Drug Report Years Considered
Figure 15. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Dermatology OTC Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Dermatology OTC Drug Market Share by Region: 2022 VS 2033
Figure 18. Global Dermatology OTC Drug Market Share by Players in 2022
Figure 19. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2022
Figure 21. North America Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Dermatology OTC Drug Market Share by Type (2018-2033)
Figure 23. North America Dermatology OTC Drug Market Share by Application (2018-2033)
Figure 24. North America Dermatology OTC Drug Market Share by Country (2018-2033)
Figure 25. United States Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Dermatology OTC Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Dermatology OTC Drug Market Share by Type (2018-2033)
Figure 29. Europe Dermatology OTC Drug Market Share by Application (2018-2033)
Figure 30. Europe Dermatology OTC Drug Market Share by Country (2018-2033)
Figure 31. Germany Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Dermatology OTC Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Dermatology OTC Drug Market Share by Type (2018-2033)
Figure 39. China Dermatology OTC Drug Market Share by Application (2018-2033)
Figure 40. Asia Dermatology OTC Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Dermatology OTC Drug Market Share by Type (2018-2033)
Figure 42. Asia Dermatology OTC Drug Market Share by Application (2018-2033)
Figure 43. Asia Dermatology OTC Drug Market Share by Region (2018-2033)
Figure 44. Japan Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Dermatology OTC Drug Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Dermatology OTC Drug Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Dermatology OTC Drug Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Dermatology OTC Drug Market Share by Country (2018-2033)
Figure 54. Brazil Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Dermatology OTC Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 61. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 62. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 63. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 64. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 65. Viatris Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 67. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 68. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 69. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 70. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 71. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 72. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 73. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 74. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 75. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 76. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries